Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Transportation & Logistics Systems M&A Deal Update
Transportation and Logistics Systems, Inc. filed an 8-K under Item 1.01 indicating the entry into a material definitive agreement. While the specific counterparty and deal value were not detailed in the provided text, the filing emphasizes the company's strategy of growing through the integration of acquisitions and the future acquisition of other businesses.
Wetouch Technology Inc. closed a private placement of 31,037,830 shares of common stock at $1.25 per share, generating gross proceeds of approximately $38.8 million. The transaction followed stockholder approval at a special meeting and was conducted as an unregistered sale of equity securities to Qixun Technology and Qihong Technology.
Value
$38.8M
Counterparty
Qixun Technology (Samoa) Limited and Qihong Technology (Samoa) Limited
SCWorx Corp. received a delisting decision from the Nasdaq Hearings Panel on September 17, 2026, due to a deficiency in publicly held shares following a reverse stock split. The company has requested reconsideration of the decision, claiming it cured the deficiency by issuing 449,860 shares in a private placement on September 16. To regain compliance, the company must also maintain a minimum bid price of $1.00 for 10 consecutive days by October 5, 2026.
StratCap Digital Infrastructure REIT M&A Deal Update
StratCap Digital Infrastructure REIT has concluded its previously announced strategic alternatives review process and decided not to pursue a sale of the company at this time. The board and its financial advisor engaged with potential counterparties but will now focus on managing the capital structure and evaluating other alternatives such as individual asset sales or special distributions.
Fifth Third Bancorp announced the expiration and results of its registered exchange offer for two series of senior notes totaling approximately $1.27 billion in principal. The company accepted $334.4 million of 4.000% Senior Notes due 2029 and $938.1 million of 5.982% Fixed-To-Floating Rate Senior Notes due 2030 for exchange into registered securities with substantially identical terms.
FMC Corporation completed a $403.2 million equity investment from Tessenderlo Group NV, which purchased approximately 30.3 million shares to reach a 20% ownership stake. As part of the deal, Tessenderlo Group gains the right to nominate one independent director to the FMC Board and is subject to a three-year lock-up period and customary standstill restrictions.
KKR Infrastructure Conglomerate Capital Raise of $205M
KKR Infrastructure Conglomerate LLC sold approximately $205.3 million in unregistered Class I, Class S, and Class D shares for cash on September 1, 2026. This sale is part of a continuous private offering that has raised approximately $7,979 million since the company's inception in June 2023.
Raymond James Financial reported record assets under administration of $1.97 trillion for August 2026, representing a 16% increase year-over-year. The growth was driven by higher equity markets and net asset inflows from advisor retention and recruiting, while domestic cash sweep and Enhanced Savings Program balances reached $57.4 billion.
Bath & Body Works granted a performance stock unit (PSU) award with a target value of $10 million to its CEO, Daniel Heaf. The award is tied to rigorous stock price performance hurdles ranging from $40 to $100 per share over a four-year performance period and includes a total shareholder return (TSR) modifier.
Teamshares Inc. closed a $222.75 million preferred equity investment through the sale of 225,000 shares of newly designated Series A Preferred Stock to affiliates of T. Rowe Price. The non-convertible, non-voting perpetual preferred stock was issued at $990 per share (a 1% original issue discount) and is intended to fund the company's programmatic acquisition strategy of small and medium-sized enterprises.
Braemar Hotels & Resorts Inc. has postponed its 2026 Annual Meeting of Stockholders. Originally scheduled for November 13, 2026, the meeting will now be held on December 21, 2026.
Jacobs Solutions Inc. reported a change in its senior leadership or board of directors under Item 5.02. The filing indicates the departure, election, or appointment of a director or certain senior officers, though specific names and roles were not detailed in the metadata.
Clarivate $75M Debt Financing with Clarivate Science Holdings Corporation
Clarivate Plc's subsidiary, Clarivate Science Holdings Corporation, announced the pricing terms for its cash tender offer to repurchase up to $75 million in aggregate principal amount of its 3.875% Senior Secured Notes due 2028. The total consideration was set at $975.15 per $1,000 principal amount of notes, based on a fixed spread of 50 basis points over the reference U.S. Treasury yield.
Theravance Biopharma, Inc. completed its merger with Zymeworks Inc., becoming a wholly owned subsidiary of Zymeworks. Shareholders received $17.00 in cash per share plus one contingent value right (CVR) per share. The transaction was finalized on September 23, 2026, following the original merger agreement signed in June 2026.
Covista $510M Debt Financing with Morgan Stanley Senior Funding, Inc.
Covista Inc. entered into Amendment No. 6 to its existing Credit Agreement to reprice $510 million in outstanding term loans. The amendment reduces the interest rate from Term SOFR plus 2.25% to Term SOFR plus 2.00%, effectively lowering the company's borrowing costs.
Solaris Energy Infrastructure $1.25B Debt Financing with MUFG Securities Americas Inc.
Solaris Energy Infrastructure, LLC, a subsidiary of Solaris Energy Infrastructure, Inc., priced an upsized private placement of $1.25 billion in 7.000% Senior Notes due 2032. The offering was increased from an initial $1.0 billion and is expected to close on October 1, 2026. Net proceeds of approximately $1,227.2 million will be used for general corporate purposes, growth capital expenditures, and fees.
Farmers and Merchants Bancshares, Inc. has elected Mark C. Krebs to its Board of Directors as a Class I director, effective September 21, 2026. Mr. Krebs previously served as the company's Treasurer and CFO until his retirement in June 2025 and will serve on the Asset/Liability, Investor Relations, and Nominating Committees.
Orange County Bancorp, Inc. released an investor presentation deck to be reviewed with analysts and institutional investors at the Stephens Bank Forum 2026 on September 24, 2026. The materials provide updates on the company's operating and growth strategies, as well as its financial performance through the second quarter of 2026.
NeoVolta reported fiscal year 2026 revenue of $13.3 million, a 58% increase year-over-year, despite a significant fourth-quarter revenue decline due to residential tax law changes. The company posted a GAAP net loss of $21.5 million for the year as it transitions into a multi-market energy storage platform through its NeoVolta Power manufacturing joint venture.
Jazz Pharmaceuticals $1.9B Debt Financing with Bank of America, N.A.
Jazz Pharmaceuticals' subsidiary, Jazz Financing Lux S.à r.l., entered into a repricing amendment to its credit agreement to refinance $1.895 billion in outstanding term loans. The new Tranche B-3 Dollar Term Loans extend the maturity date from May 2028 to May 2033 and reduce the interest rate margin by 50 basis points to Term SOFR plus 1.75%.
HealthStream's Compensation Committee approved special grants of time-based and performance-based restricted share units (RSUs) to its named executive officers under the 2022 Omnibus Incentive Plan. The grants, which include awards to CEO Robert A. Frist, Jr. and CFO Scott A. Roberts, are designed to incentivize future performance and retention with vesting schedules extending through 2030.
Blue Owl Credit Income Corp. sold 191,466 unregistered Class I common shares for $1.75 million in a private placement to feeder vehicles. The company also provided an update on its continuous public offering, which has raised approximately $22.5 billion in total proceeds to date across its public and private offerings.
Sarepta Therapeutics entered into a settlement agreement with REGENXBIO, the University of Pennsylvania, and Catalent to resolve pending patent infringement litigation regarding the '274 and '617 patents. Sarepta will pay a lump sum of $39.0 million to REGENXBIO in exchange for a release of claims and a covenant not to sue regarding Sarepta's gene therapy products using the AAVrh74-based capsid, including ELEVIDYS. The settlement resolves all pending litigations with prejudice and includes no admission of liability.
Leader's Advantage Acquisition Capital Raise of $150M
Leader’s Advantage Acquisition Corp. consummated its initial public offering (IPO) of 15,000,000 units at $10.00 per unit, generating gross proceeds of $150 million. Each unit consists of one Class A ordinary share and one-half of one redeemable warrant, with the units trading on Nasdaq under the symbol LEDRU. The company has granted underwriters a 45-day option to purchase up to an additional 2,250,000 units to cover over-allotments.
Arcturus Therapeutics Holdings Clinical Trial Data
Arcturus Therapeutics released Phase 2 clinical data for ARCT-810, its mRNA-based therapeutic candidate for Ornithine Transcarbamylase (OTC) deficiency. The company also provided a strategic update on its broader mRNA delivery platform and technology pipeline.
Ready Capital $100M Debt Financing with U.S. Bank Trust Company, National Association
Ready Capital Corporation entered into a supplemental indenture to amend the terms of its $100 million 7.375% Senior Notes due 2027. The amendment, approved by a majority of noteholders, relaxes the Recourse Debt to Equity Ratio to 2.0 to 1.0 and adjusts the minimum Consolidated Net Asset Value covenant to $1.2 billion plus equity activity adjustments.
VSee Health, Inc. has filed a Certificate of Amendment to effect a 1-for-80 reverse stock split of its common stock, effective September 23, 2026. The stock will begin trading on a split-adjusted basis on September 24, 2026, under a new CUSIP number. No fractional shares will be issued, with any resulting fractions rounded up to the next whole number.
Blue Owl Technology Income Corp. declared monthly distributions for its Class S, Class D, and Class I shares, with a gross distribution of $0.074775 per share payable in October and November 2026. The filing also provided a routine update on its continuous public offering, which has raised approximately $4.07 billion to date, and reported an August 31, 2026 net asset value (NAV) of $9.75 per share across all classes.
MariMed Inc. has filed a definitive proxy statement for a special meeting of stockholders to seek approval for a reverse stock split at a ratio between 1-for-50 and 1-for-100. The move is intended to increase the share price to satisfy listing requirements for a potential move to a major U.S. national securities exchange. The special meeting is scheduled for October 28, 2026.
Gossamer Bio has submitted its first New Drug Application (NDA) to the FDA for seralutinib for the treatment of pulmonary arterial hypertension (PAH). The submission is supported by data from the Phase 3 PROSERA and Phase 2 TORREY studies, following a Pre-NDA meeting with the regulator in June 2026. The FDA is expected to determine whether to accept the application for filing later this year.